BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/21/2020 2:15:44 PM | Browse: 602 | Download: 1015
 |
Received |
|
2019-12-30 13:35 |
|
Peer-Review Started |
|
2019-12-30 13:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-01-19 00:26 |
|
Revised |
|
2020-04-20 22:08 |
|
Second Decision |
|
2020-05-29 08:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-05-29 23:23 |
|
Articles in Press |
|
2020-05-29 23:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-06-11 01:44 |
|
Publish the Manuscript Online |
|
2020-06-21 14:15 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ute Warnecke-Eberz, Patrick Plum, Viola Schweinsberg, Uta Drebber, Christiane J Bruns, Dolores T Müller, Arnulf H Hölscher and Elfriede Bollschweiler |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ute Warnecke-Eberz, PhD, Professor, Department of General, Visceral and Cancer Surgery, University Hospital of Cologne, Kerpener Str. 62, Cologne 50937, Germany. ute.warnecke-eberz@uk-koeln.de |
| Key Words |
Esophageal cancer; Response prediction; Prognosis; D2-40; Posttranscriptional regulation; miRNA-363 |
| Core Tip |
Podoplanin is an oncofetal membrane protein, re-expressed in squamous cell carcinoma of the esophagus. Podoplanin expression seems to be, among others, controlled by miR-363. Chemoradiation results in reduction of podoplanin protein expression, and furthermore, podoplanin is a prognostic factor for survival. This implicates that a decrease of podoplanin might become a therapeutic option. |
| Publish Date |
2020-06-21 14:15 |
| Citation |
Warnecke-Eberz U, Plum P, Schweinsberg V, Drebber U, Bruns CJ, Müller DT, Hölscher AH, Bollschweiler E. Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients. World J Gastroenterol 2020; 26(23): 3236-3248 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i23/3236.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i23.3236 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
